These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30664937)

  • 41. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery.
    Chen SD; Li HQ; Cui M; Dong Q; Yu JT
    Expert Opin Drug Discov; 2020 Sep; 15(9):1081-1094. PubMed ID: 32425128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.
    Lee C; Willerth SM; Nygaard HB
    Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders.
    Vaccarino FM; Stevens HE; Kocabas A; Palejev D; Szekely A; Grigorenko EL; Weissman S
    Neuropharmacology; 2011 Jun; 60(7-8):1355-63. PubMed ID: 21371482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease Modeling.
    Matsumoto T; Fujimori K; Andoh-Noda T; Ando T; Kuzumaki N; Toyoshima M; Tada H; Imaizumi K; Ishikawa M; Yamaguchi R; Isoda M; Zhou Z; Sato S; Kobayashi T; Ohtaka M; Nishimura K; Kurosawa H; Yoshikawa T; Takahashi T; Nakanishi M; Ohyama M; Hattori N; Akamatsu W; Okano H
    Stem Cell Reports; 2016 Mar; 6(3):422-35. PubMed ID: 26905201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induced pluripotent stem cells to model and treat neurogenetic disorders.
    Wang H; Doering LC
    Neural Plast; 2012; 2012():346053. PubMed ID: 22888453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease.
    Inak G; Lorenz C; Lisowski P; Zink A; Mlody B; Prigione A
    Stem Cells; 2017 Jul; 35(7):1655-1662. PubMed ID: 28544378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling of psychiatric disorders using induced pluripotent stem cell-related technologies.
    Nakazawa T; Hashimoto R; Takuma K; Hashimoto H
    J Pharmacol Sci; 2019 Aug; 140(4):321-324. PubMed ID: 31257060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
    Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
    N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
    van Hugte E; Nadif Kasri N
    Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concise review: drug discovery in the age of the induced pluripotent stem cell.
    Ko HC; Gelb BD
    Stem Cells Transl Med; 2014 Apr; 3(4):500-9. PubMed ID: 24493856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-Organized Cerebellar Tissue from Human Pluripotent Stem Cells and Disease Modeling with Patient-Derived iPSCs.
    Muguruma K
    Cerebellum; 2018 Feb; 17(1):37-41. PubMed ID: 29196977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induced pluripotent stem cells and neurological disease models.
    Cai S; Chan YS; Shum DK
    Sheng Li Xue Bao; 2014 Feb; 66(1):55-66. PubMed ID: 24553870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concise review: modeling central nervous system diseases using induced pluripotent stem cells.
    Zeng X; Hunsberger JG; Simeonov A; Malik N; Pei Y; Rao M
    Stem Cells Transl Med; 2014 Dec; 3(12):1418-28. PubMed ID: 25368377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induced pluripotent stem cells for the treatment of stroke: the potential and the pitfalls.
    Yu F; Li Y; Morshead CM
    Curr Stem Cell Res Ther; 2013 Sep; 8(5):407-14. PubMed ID: 23895059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.
    Sanchez-Danes A; Benzoni P; Memo M; Dell'Era P; Raya A; Consiglio A
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1114-27. PubMed ID: 24040813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.
    Sayed N; Liu C; Wu JC
    J Am Coll Cardiol; 2016 May; 67(18):2161-2176. PubMed ID: 27151349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.
    Ye L; Ni X; Zhao ZA; Lei W; Hu S
    J Cardiovasc Transl Res; 2018 Oct; 11(5):366-374. PubMed ID: 29845439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.